3,3'-diaminobenzidine has been researched along with Multiple Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buneva, VN; Nevinsky, GA; Tolmacheva, AS | 1 |
1 other study(ies) available for 3,3'-diaminobenzidine and Multiple Sclerosis
| Article | Year |
|---|---|
Substrate specificity of IgGs with peroxidase and oxidoreductase activities from sera of patients with systemic lupus erythematosus and multiple sclerosis.
Topics: 3,3'-Diaminobenzidine; Adult; Female; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Male; Middle Aged; Multiple Sclerosis; Oxidation-Reduction; Oxidoreductases; Peroxidases; Substrate Specificity; Young Adult | 2019 |